PD-1 Inhibitors
2 stories
-
healthDeep Learning Outperforms Radiomics in Predicting Immunotherapy Outcomes in NSCLC
Deep learning models show superior accuracy over radiomics in predicting immunotherapy outcomes for metastatic NSCLC, promising better treatment personalization.
-
healthHeart Failure Risk Surges for Cancer Patients on PD-1 Inhibitors
New study reveals a significantly increased risk of heart failure in cancer patients treated with PD-1 inhibitors, especially those with a history of heart disease.